Sutton Wealth Advisors Inc. Biomarin Pharmaceutical Inc Transaction History

Sutton Wealth Advisors Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Nov 07, 2023	BUY	$71.72 - $91.47 $1,075 - $1,372	15 New	15 $1.33 Million
Q4 2019 Nov 07, 2023	SELL	$64.27 - $86.37 $578 - $777	-9 Reduced 9.89%	82 $6.93 Million
Q3 2019 Nov 07, 2023	SELL	$67.4 - $85.11 $202 - $255	-3 Reduced 3.19%	91 $6.13 Million
Q2 2019 Nov 06, 2023	SELL	$80.35 - $93.9 $241 - $281	-3 Reduced 3.09%	94 $8.05 Million
Q1 2019 Nov 06, 2023	BUY	$84.2 - $98.62 $757 - $887	9 Added 10.23%	97 $8.62 Million
Q4 2018 Nov 06, 2023	BUY	$80.14 - $106.07 $6,571 - $8,697	82 Added 1366.67%	88 $7.49 Million
Q3 2018 Nov 06, 2023	SELL	$93.92 - $105.72 $23,573 - $26,535	-251 Reduced 97.67%	6 $582,000
Q4 2016 Nov 06, 2023	BUY	N/A	3 Added 1.18%	257 $21.3 Million
Q1 2016 Nov 06, 2023	BUY	N/A	254	254 $21 Million

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.